Extended-Release Quetiapine as Adjunct to an Antidepressant in Patients With Major Depressive Disorder
2009 · The Journal of Clinical Psychiatry · 203 citations
https://doi.org/10.4088/jcp.08m04629
W
Willie Earley
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
114
Papers
3.3K
Citations
32
h-index
51
i10-index
Willie Earley is an academic researcher from Johnson & Johnson (United States). The author has contributed to research in topics: Schizophrenia research and treatment & Bipolar Disorder and Treatment & Treatment of Major Depression. The author has an h-index of 32, co-authored 97 publications.
Papers by this author
worksLong-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder
2018 · International Clinical Psychopharmacology · 187 citations
https://doi.org/10.1097/yic.0000000000000246
Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants
2016 · The Journal of Clinical Psychiatry · 119 citations
https://doi.org/10.4088/jcp.15m10070
Efficacy and tolerability of extended release quetiapine fumarate (quetiapine XR) monotherapy in major depressive disorder: A placebo-controlled, randomized study☆
2010 · Journal of Affective Disorders · 80 citations
https://doi.org/10.1016/j.jad.2010.06.031
The safety and tolerability of cariprazine in long-term treatment of schizophrenia: a post hoc pooled analysis
2017 · BMC Psychiatry · 79 citations
https://doi.org/10.1186/s12888-017-1459-z
Randomized, Double-Blind Study of the Efficacy and Tolerability of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Elderly Patients with Major Depressive Disorder
2013 · American Journal of Geriatric Psychiatry · 58 citations
https://doi.org/10.1016/j.jagp.2013.01.010
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat